Previous close | 13.23 |
Open | 12.94 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 12.40 - 13.26 |
52-week range | 11.92 - 53.20 |
Volume | |
Avg. volume | 1,508,225 |
Market cap | 1.391B |
Beta (5Y monthly) | 1.48 |
PE ratio (TTM) | 14.96 |
EPS (TTM) | 0.84 |
Earnings date | 16 Feb 2022 - 21 Feb 2022 |
Forward dividend & yield | 0.90 (3.92%) |
Ex-dividend date | 14 May 2021 |
1y target est | 28.67 |
Paris, 30 June, 2022 - Atos, in agreement with the Wellcome Genome Campus in Cambridgeshire, UK, today announces the official opening of its global Life Sciences Centre of Excellence. The facility will provide scientists on campus, and global genome and bio-data institutes worldwide, early access to emerging technologies to support their research, helping to accelerate the process of bringing new drugs to market and delivering tangible societal benefits. The Atos Life Sciences Centre of Excellen
Paris, France and Brasov, Romania – June 29, 2022 - Atos today announced it has been awarded a 1.2 million euros contract by the NATO Communications and Information Agency (NCI Agency) to install and configure mission critical cybersecurity capabilities and systems at 22 NATO sites. Atos, number 1 worldwide managed security services provider, with a strong focus on resilience and mission critical assets, has also an extensive experience in supporting clients in the defense sector. The Group will
A strategic collaboration to develop and commercialize a unique technology solution to collect and analyze manufacturing data on a large scale.A new step towards industry digitalization by improving the operational performance of manufacturing equipment: helping to enable better productivity, fewer defects, and lower energy consumption. This collaboration leverages Renault Group’s expertise and experience in the digital transformation of its manufacturing activities as well as capitalizing on At